Aiming for a well-being society
Our company's management vision for 2030 is "Connect for Well-being," and we are engaged in four business areas: eye care, skin care, oral medications and food, and medical (prescription ophthalmic drugs, Regenerative medicine, and CDMO).
We are working with external organizations to find unmet needs in the gaps between these business areas, generate innovation, and promote co-creation in order to realize synergies through various combinations.
By deepening our global connections that transcend regions and rapidly incorporating the latest knowledge and technology, we aim to provide new value to our customers in order to realize a sustainable "well-being society." We aim to maximize synergies through various means, including joint research, partnerships, M&A, and collaboration with local governments, and to achieve sustainable growth and provide value for the future.
Co-creation achievements
Number of achievements
New capital alliances and investments
We are actively investing in four business areas to enhance synergies with our own businesses.
(April 2020 to March 2025)
joint research
In addition to independent research, we actively engage in joint research with external partners in four business areas. We also collaborate with academic institutions such as university research institutes to promote innovative research that will continue into the future by combining the knowledge of both parties.
(April 2021 to March 2025)
More than 200 cases
Regional Cooperation Agreement
From Hokkaido in the north to Ishigaki Island in Okinawa in the south, we have concluded partnership agreements centered on health, agriculture, and regional revitalization. We work with local governments and stakeholders to contribute to the well-being of the region.
Please see
here for specific examples of our co-creation achievements (releases).